Neuroparasitic Infections: Cestodes, Trematodes, and Protozoans (original) (raw)

ABSTRACT

Parasitic infection of the nervous system can produce a variety of symptoms and signs. Because symptoms of infection are often mild or nonspecific, diagnosis can be difficult. Familiarity with basic epidemiological characteristics and distinguishing radiographic findings can increase the likelihood of detection and proper treatment of parasitic infection of the nervous system. This article discusses the clinical presentation, diagnosis, and treatment for some of the more common infections of the nervous system caused by cestodes, trematodes and protozoans: Echinococcus spp., Spirometra spp. (sparganosis), Paragonimus spp., Schistosoma spp., Trypanosoma spp., Naegleria fowlerii, Acanthamoeba histolytica, and Balamuthia mandrillaris.

KEYWORDS

Parasite - nervous system - cestodes - trematode - protozoan

REFERENCES

• 1 Algros M P, Majo F, Bresson-Hadni S et al.. Intracerebral alveolar echinococcosis. Infection. 2003; 31 63-65
• 2 Al Zain T J, Al-Witry S H, Khalili H M et al.. Multiple intracranial hydatidosis. Acta Neurochir (Wien). 2002; 144 1179-1185
• 3 Lewall D B. Hydatid disease: biology, pathology, imaging and classification. Clin Radiol. 1998; 53 863-874
• 4 Kern P, Bardonnet K, Renner E et al.. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982-2000. Emerg Infect Dis. 2003; 9 343-349
• 5 Bouree P. Hydatidosis: dynamics of transmission. World J Surg. 2001; 25 4-9
• 6 Garret M, Herbsman H, Fierst S. Cytologic diagnosis of echinococcosis. Acta Cytol. 1977; 21 553-554
• 7 Farmer P M, Chatterley S, Spier N. Echinococcal cyst of the liver: diagnosis and surgical management. Ann Clin Lab Sci. 1990; 20 385-391
• 8 Gottstein B, Reichen J. Hydatid lung disease (echinococcosis/hydatidosis). Clin Chest Med. 2002; 23 397-408
• 9 Ramadan N I, Abel Aaty H E, Mahmoud M S, El Nori A. An enzyme-linked immunoelectrotransfer blot assay for diagnosis of human cystic echinococcosis. J Egypt Soc Parasitol. 1999; 29 849-857
• 10 Jiang L, Wen H, Ito A. Immunodiagnostic differentiation of alveolar and cystic echinococcosis using ELISA test with 18-kDa antigen extracted from Echinococcus protoscoleces. Trans R Soc Trop Med Hyg. 2001; 95 285-288
• 11 Kanwar J R, Kaushik S P, Sawhney I M et al.. Specific antibodies in serum of patients with hydatidosis recognised by immunoblotting. J Med Microbiol. 1992; 36 46-51
• 12 Gottstein B. Molecular and immunological diagnosis of echinococcosis. Clin Microbiol Rev. 1992; 5 248-261
• 13 Tuzun M, Altinors N, Arda I S, Hekimoglu B. Cerebral hydatid disease CT and MR findings. Clin Imaging. 2002; 26 353-357
• 14 CDC .DPDx Laboratory diagnosis of parasites of public health concern. Vol. 2003: Centers for Disease Control and Prevention 2003
• 15 el-Mufti M, Kamag A, Ibrahim H et al.. Albendazole therapy of hydatid disease: 2-year follow-up of 40 cases. Ann Trop Med Parasitol. 1993; 87 241-246
• 16 Lee K J, Bae Y T, Kim D H et al.. A seroepidemiologic survey for human sparganosis in Gangweon-do. Korean J Parasitol. 2002; 40 177-180
• 17 Landero A, Hernandez F, Abasolo M A et al.. Cerebral sparganosis caused by Spirometra mansonoides. Case report. J Neurosurg. 1991; 75 472-474
• 18 Noya O, Alarcon de Noya B, Arrechedera H et al.. Sparganum proliferum: an overview of its structure and ultrastructure. Int J Parasitol. 1992; 22 631-640
• 19 Fontan R, Beauchamp F, Beaver P C. [New helminthiases in Laos. II. Plathelminths]. Bull Soc Pathol Exot Filiales. 1975; 68 566-573
• 20 Li X. Food-borne parasitic zoonoses in the People's Republic of China. Southeast Asian J Trop Med Public Health. 1991; 22(suppl) 31-35
• 21 Hughes A J, Biggs B A. Parasitic worms of the central nervous system: an Australian perspective. Intern Med J. 2002; 32 541-553
• 22 Schmid H, Watschinger H. Sparganosis in the Masailand. Acta Trop. 1972; 29 218-230
• 23 Moulinier R, Martinez E, Torres J et al.. Human proliferative sparganosis in Venezuela: report of a case. Am J Trop Med Hyg. 1982; 31 358-363
• 24 Cummings T J, Madden J F, Gray L et al.. Parasitic lesion of the insula suggesting cerebral sparganosis: case report. Neuroradiology. 2000; 42 206-208
• 25 Gray M L, Rogers F, Little S et al.. Sparganosis in feral hogs (Sus scrofa) from Florida. J Am Vet Med Assoc. 1999; 215 204-208
• 26 Park H Y, Lee S U, Kim S H et al.. Epidemiological significance of sero-positive inhabitants against sparganum in Kangwon-do, Korea. Yonsei Med J. 2001; 42 371-374
• 27 Mastura A B, Ambu S, Hasnah O, Rosli R. Spargana infection of frogs in Malaysia. Southeast Asian J Trop Med Public Health. 1996; 27 51-52
• 28 Tsou M H, Huang T W. Pathology of subcutaneous sparganosis: report of two cases. J Formos Med Assoc. 1993; 92 649-653
• 29 Kron M A, Guderian R, Guevara A, Hidalgo A. Abdominal sparganosis in Ecuador: a case report. Am J Trop Med Hyg. 1991; 44 146-150
• 30 Rywlin A M, Beck J W, Snyder G B. Sparganosis in Florida. Arch Dermatol. 1968; 97 425-427
• 31 Norman S H, Kreutner Jr A. Sparganosis: clinical and pathologic observations in ten cases. South Med J. 1980; 73 297-300
• 32 Taylor R L. Sparganosis in the United States. Report of a case. Am J Clin Pathol. 1976; 66 560-564
• 33 Mueller J F. Potential longevity of life history stages of Spirometra spp. J Parasitol. 1974; 60 376-377
• 34 Chang J H, Lin O S, Yeh K T. Subcutaneous sparganosis-a case report and a review of human sparganosis in Taiwan. Kaohsiung J Med Sci. 1999; 15 567-571
• 35 Pampiglione S, Fioravanti M L, Rivasi F. Human sparganosis in Italy. Case report and review of the European cases. APMIS. 2003; 111 349-354
• 36 Chang K H, Chi J G, Cho S Y et al.. Cerebral sparganosis: analysis of 34 cases with emphasis on CT features. Neuroradiology. 1992; 34 1-8
• 37 Botterel F, Bouree P. Ocular sparganosis: a case report. J Travel Med. 2003; 10 245-246
• 38 Campbell E W, Beals C. Striking eosinophilia in sparganosis. Postgrad Med. 1977; 62 138-140
• 39 Fan K J, Pezeshkpour G H. Cerebral sparganosis. Neurology. 1986; 36 1249-1251
• 40 Sarma D P, Weilbaecher T G. Human sparganosis. J Am Acad Dermatol. 1986; 15 1145-1148
• 41 Nishiyama T, Ide T, Himes Jr S R et al.. Immunodiagnosis of human sparganosis mansoni by micro-chemiluminescence enzyme-linked immunosorbent assay. Trans R Soc Trop Med Hyg. 1994; 88 663-665
• 42 Moon W K, Chang K H, Cho S Y et al.. Cerebral sparganosis: MR imaging versus CT features. Radiology. 1993; 188 751-757
• 43 Jeong S C, Bae J C, Hwang S H et al.. Cerebral sparganosis with intracerebral hemorrhage: a case report. Neurology. 1998; 50 503-506
• 44 Han S R, Park J K, Kim Y I, Son B C. Posterior cerebral artery infarction caused by cerebral sparganosis-induced vasculitis. Eur Neurol. 2001; 46 105-107
• 45 Ishii H, Mukae H, Inoue Y et al.. A rare case of eosinophilic pleuritis due to sparganosis. Intern Med. 2001; 40 783-785
• 46 Kim D G, Paek S H, Chang K H et al.. Cerebral sparganosis: clinical manifestations, treatment, and outcome. J Neurosurg. 1996; 85 1066-1071
• 47 Torres J R, Noya O O, Noya B A et al.. Treatment of proliferative sparganosis with mebendazole and praziquantel. Trans R Soc Trop Med Hyg. 1981; 75 846-847
• 48 Blair D, Xu Z B, Agatsuma T. Paragonimiasis and the genus Paragonimus. Adv Parasitol. 1999; 42 113-222
• 49 Kim D C. Paragonimus westermani: life cycle, intermediate hosts, transmission to man and geographical distribution in Korea. Arzneimittelforschung. 1984; 34 1180-1183
• 50 Miyazaki I, Hirose H. Immature lung flukes first found in the muscle of the wild boar in Japan. J Parasitol. 1976; 62 836-837
• 51 Choi W Y. Paragonimus westermani: pathogenesis and clinical features of infection. Arzneimittelforschung. 1984; 34 1184-1185
• 52 Oh S J. Cerebral and spinal paragonimiasis. A histopathological study. J Neurol Sci. 1969; 9 205-236
• 53 Kusner D J, King C H. Cerebral paragonimiasis. Semin Neurol. 1993; 13 201-208
• 54 Ashitani J, Kumamoto K, Matsukura S. Paragonimiasis westermani with multifocal lesions in lungs and skin. Intern Med. 2000; 39 433-436
• 55 Kagawa F T. Pulmonary paragonimiasis. Semin Respir Infect. 1997; 12 149-158
• 56 Kang S Y, Kim T K, Kim T Y et al.. A case of chronic cerebral paragonimiasis westermani. Korean J Parasitol. 2000; 38 167-171
• 57 Kan H, Ogata T, Taniyama A et al.. Extraordinarily high eosinophilia and elevated serum interleukin-5 level observed in a patient infected with Paragonimus westermani. Pediatrics. 1995; 96 351-354
• 58 Kim T Y, Joo I J, Kang S Y et al.. Recombinant Paragonimus westermani yolk ferritin is a useful serodiagnostic antigen. J Infect Dis. 2002; 185 1373-1375
• 59 Oh S J. Paragonimus meningitis. J Neurol Sci. 1968; 6 419-433
• 60 Yoshida M, Moritaka K, Kuga S, Anegawa S. CT findings of cerebral paragonimiasis in the chronic state. J Comput Assist Tomogr. 1982; 6 195-196
• 61 Udaka F, Okuda B, Okada M et al.. CT findings of cerebral paragonimiasis in the chronic state. Neuroradiology. 1988; 30 31-34
• 62 El-Garem A A. Schistosomiasis. Digestion. 1998; 59 589-605
• 63 Pittella J E. Neuroschistosomiasis. Brain Pathol. 1997; 7 649-662
• 64 Zheng J, Gu X G, Xu Y L et al.. Relationship between the transmission of schistosomiasis japonica and the construction of the Three Gorge Reservoir. Acta Trop. 2002; 82 147-156
• 65 Babiker S M, Blankespoor H D, Wassila M et al.. Transmission of Schistosoma haematobium in North Gezira, Sudan. J Trop Med Hyg. 1985; 88 65-73
• 66 Liu L X. Spinal and cerebral schistosomiasis. Semin Neurol. 1993; 13 189-200
• 67 Pollner J H, Schwartz A, Kobrine A, Parenti D M. Cerebral schistosomiasis caused by Schistosoma haematobium: case report. Clin Infect Dis. 1994; 18 354-357
• 68 Haedicke T A. Cerebral schistosomiasis. A report of 10 cases caused by Schistosomiasis japonica. Minn Med. 1972; 55 1105-1114
• 69 Pittella J E. The relation between involvement of the central nervous system in schistosomiasis mansoni and the clinical forms of the parasitosis. A review. J Trop Med Hyg. 1991; 94 15-21
• 70 Scrimgeour E M, Gajdusek D C. Involvement of the central nervous system in Schistosoma mansoni and S. haematobium infection. A review. Brain. 1985; 108 1023-1038
• 71 File S. Interaction of schistosome eggs with vascular endothelium. J Parasitol. 1995; 81 234-238
• 72 Stuiver P C. Acute schistosomiasis (Katayama fever). Br Med J (Clin Res Ed). 1984; 288 221-222
• 73 King C H, Mahmoud A A. Drugs five years later: praziquantel. Ann Intern Med. 1989; 110 290-296
• 74 Jukes M C, Nokes C A, Alcock K J et al.. Heavy schistosomiasis associated with poor short-term memory and slower reaction times in Tanzanian schoolchildren. Trop Med Int Health. 2002; 7 104-117
• 75 Brinkmann U K, Powollik W, Werler C, Traore M. An evaluation of sampling methods within communities and the validity of parasitological examination techniques in the field. Trop Med Parasitol. 1988; 39 162-166
• 76 Ferrari T C, Moreira P R, Oliveira R C et al.. The value of an enzyme-linked immunosorbent assay for the diagnosis of schistosomiasis mansoni myeloradiculopathy. Trans R Soc Trop Med Hyg. 1995; 89 496-500
• 77 Gjerde I O, Mork S, Larsen J L et al.. Cerebral schistosomiasis presenting as a brain tumor. Eur Neurol. 1984; 23 229-236
• 78 Fowler R, Lee C, Keystone J S. The role of corticosteroids in the treatment of cerebral schistosomiasis caused by Schistosoma mansoni: case report and discussion. Am J Trop Med Hyg. 1999; 61 47-50
• 79 Ching H T, Clark A E, Hendrix V J et al.. MR imaging appearance of intracerebral schistosomiasis. AJR Am J Roentgenol. 1994; 162 693-694
• 80 Preidler K W, Riepl T, Szolar D, Ranner G. Cerebral schistosomiasis: MR and CT appearance. AJNR Am J Neuroradiol. 1996; 17 1598-1600
• 81 Kardaman M W, Amin M A, Fenwick A et al.. A field trial using praziquantel (BiltricideR) to treat Schistosoma mansoni and Schistosoma haematobium infection in Gezira, Sudan. Ann Trop Med Parasitol. 1983; 77 297-304
• 82 Watt G, Adapon B, Long G W et al.. Praziquantel in treatment of cerebral schistosomiasis. Lancet. 1986; 2 529-532
• 83 Ferrari M L, Coelho P M, Antunes C M et al.. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial. Bull World Health Organ. 2003; 81 190-196
• 84 Xiao S, Tanner M, N'Goran E K et al.. Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop. 2002; 82 175-181
• 85 Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz. 2003; 98 577-591
• 86 Busch M P, Kleinman S H, Nemo G J. Current and emerging infectious risks of blood transfusions. JAMA. 2003; 289 959-962
• 87 Dias J C, Silveira A C, Schofield C J. The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz. 2002; 97 603-612
• 88 Leiby D A, Herron Jr R M, Read E J et al.. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion. 2002; 42 549-555
• 89 Sanchez-Guillen M C, Barnabe C, Guegan J F et al.. High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the State of Puebla, a non-endemic area of Mexico. Mem Inst Oswaldo Cruz. 2002; 97 947-952
• 90 Leiguarda R, Roncoroni A, Taratuto A L et al.. Acute CNS infection by Trypanosoma cruzi (Chagas' disease) in immunosuppressed patients. Neurology. 1990; 40 850-851
• 91 Kirk M L, Schofield C J. Density-dependent timing of defaecation by Rhodnius prolixus, and its implications for the transmission of Trypanosoma cruzi. Trans R Soc Trop Med Hyg. 1987; 81 348-349
• 92 Hall B F, Joiner K A. Developmentally-regulated virulence factors of Trypanosoma cruzi and their relationship to evasion of host defences. J Eukaryot Microbiol. 1993; 40 207-213
• 93 Anez N, Carrasco H, Parada H et al.. Acute Chagas' disease in western Venezuela: a clinical, seroparasitologic, and epidemiologic study. Am J Trop Med Hyg. 1999; 60 215-222
• 94 Delaporte F. Romana's sign. J Hist Biol. 1997; 30 357-366
• 95 Dias J C. [Cecilio Romana, Romana's sign and Chagas' disease]. Rev Soc Bras Med Trop. 1997; 30 407-413
• 96 Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis. 2001; 1 92-100
• 97 Bestetti R B, Muccillo G. Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy. Int J Cardiol. 1997; 60 187-193
• 98 Matsumoto T K, Hoshino-Shimizu S, Nakamura P M et al.. High resolution of Trypanosoma cruzi amastigote antigen in serodiagnosis of different clinical forms of Chagas' disease. J Clin Microbiol. 1993; 31 1486-1492
• 99 Umezawa E S, Nascimento M S, Stolf A M. Enzyme-linked immunosorbent assay with Trypanosoma cruzi excreted-secreted antigens (TESA-ELISA) for serodiagnosis of acute and chronic Chagas' disease. Diagn Microbiol Infect Dis. 2001; 39 169-176
• 100 Di Lorenzo G A, Pagano M A, Taratuto A L et al.. Chagasic granulomatous encephalitis in immunosuppressed patients. Computed tomography and magnetic resonance imaging findings. J Neuroimaging. 1996; 6 94-97
• 101 Urbina J A. Specific treatment of Chagas disease: current status and new developments. Curr Opin Infect Dis. 2001; 14 733-741
• 102 Rodriques Coura J, de Castro S L. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz. 2002; 97 3-24
• 103 Viotti R, Vigliano C, Armenti H, Segura E. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am Heart J. 1994; 127 151-162
• 104 Cerisola J A, Neves da Silva N, Prata A et al.. [Evaluation of the efficacy of nifurtimox in chronic human chagasic infection by using xenodiagnosis (author's transl)]. Bol Chil Parasitol. 1977; 32 51-62
• 105 Smith D H, Pepin J, Stich A H. Human African trypanosomiasis: an emerging public health crisis. Br Med Bull. 1998; 54 341-355
• 106 Van Nieuwenhove S, Betu-Ku-Mesu V K, Diabakana P M et al.. Sleeping sickness resurgence in the DRC: the past decade. Trop Med Int Health. 2001; 6 335-341
• 107 Welburn S C, Fevre E M, Coleman P G et al.. Sleeping sickness: a tale of two diseases. Trends Parasitol. 2001; 17 19-24
• 108 McGovern T W, Williams W, Fitzpatrick J E et al.. Cutaneous manifestations of African trypanosomiasis. Arch Dermatol. 1995; 131 1178-1182
• 109 Kristensson K, Mhlanga J D, Bentivoglio M. Parasites and the brain: neuroinvasion, immunopathogenesis and neuronal dysfunctions. Curr Top Microbiol Immunol. 2002; 265 227-257
• 110 Villanueva M S. Trypanosomiasis of the central nervous system. Semin Neurol. 1993; 13 209-218
• 111 Enanga B, Burchmore R J, Stewart M L, Barrett M P. Sleeping sickness and the brain. Cell Mol Life Sci. 2002; 59 845-858
• 112 Mhlanga J D, Bentivoglio M, Kristensson K. Neurobiology of cerebral malaria and African sleeping sickness. Brain Res Bull. 1997; 44 579-589
• 113 Lejon V, Buscher P. Stage determination and follow-up in sleeping sickness. Med Trop (Mars). 2001; 61 355-360
• 114 Gill D S, Chatha D S, del Carpio-O'Donovan R. MR imaging findings in African trypansomiasis. AJNR Am J Neuroradiol. 2003; 24 1383-1385
• 115 Nok A J. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. Parasitol Res. 2003; 90 71-79
• 116 Matovu E, Enyaru J C, Legros D et al.. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda. Trop Med Int Health. 2001; 6 407-411
• 117 Docampo R, Moreno S N. Current chemotherapy of human African trypanosomiasis. Parasitol Res. 2003; 90(suppl 1) S10-S13
• 118 Parija S C, Jayakeerthee S R. Naegleria fowleri: a free living amoeba of emerging medical importance. J Commun Dis. 1999; 31 153-159
• 119 Gyori E. December 2002: 19-year old male with febrile illness after jet ski accident. Brain Pathol. 2003; 13 237-239
• 120 Jain R, Prabhakar S, Modi M et al.. Naegleria meningitis: a rare survival. Neurol India. 2002; 50 470-472
• 121 Barnett N D, Kaplan A M, Hopkin R J et al.. Primary amoebic meningoencephalitis with Naegleria fowleri: clinical review. Pediatr Neurol. 1996; 15 230-234
• 122 Martinez A J. Free-living amebic meningoencephalitides: comparative study. Neurol Neurocir Psiquiatr. 1977; 18 391-401
• 123 Carter R F. Primary amoebic meningo-encephalitis: clinical, pathological and epidemiological features of six fatal cases. J Pathol Bacteriol. 1968; 96 1-25
• 124 Viriyavejakul P, Rochanawutanon M, Sirinavin S. Naegleria meningomyeloencephalitis. Southeast Asian J Trop Med Public Health. 1997; 28 237-240
• 125 Reveiller F L, Cabanes P A, Marciano-Cabral F. Development of a nested PCR assay to detect the pathogenic free-living amoeba Naegleria fowleri. Parasitol Res. 2002; 88 443-450
• 126 Schumacher D J, Tien R D, Lane K. Neuroimaging findings in rare amebic infections of the central nervous system. AJNR Am J Neuroradiol. 1995; 16 930-935
• 127 Ferrante A. Free-living amoebae: pathogenicity and immunity. Parasite Immunol. 1991; 13 31-47
• 128 Loschiavo F, Ventura-Spagnolo T, Sessa E, Bramanti P. Acute primary meningoencephalitis from entamoeba Naegleria Fowleri. Report of a clinical case with a favourable outcome. Acta Neurol (Napoli). 1993; 15 333-340
• 129 Seidel J S, Harmatz P, Visvesvara G S et al.. Successful treatment of primary amebic meningoencephalitis. N Engl J Med. 1982; 306 346-348
• 130 Sell J J, Rupp F W, Orrison Jr W W. Granulomatous amebic encephalitis caused by acanthamoeba. Neuroradiology. 1997; 39 434-436
• 131 Deol I, Robledo L, Meza A et al.. Encephalitis due to a free-living amoeba (Balamuthia mandrillaris): case report with literature review. Surg Neurol. 2000; 53 611-616
• 132 Healy J F. Balamuthia amebic encephalitis: radiographic and pathologic findings. AJNR Am J Neuroradiol. 2002; 23 486-489
• 133 McCulley J P, Alizadeh H, Niederkorn J Y. The diagnosis and management of Acanthamoeba keratitis. CLAO J. 2000; 26 47-51
• 134 Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev. 2003; 16 273-307
• 135 Denney C F, Iragui V J, Uber-Zak L D et al.. Amebic meningoencephalitis caused by Balamuthia mandrillaris: case report and review. Clin Infect Dis. 1997; 25 1354-1358
• 136 Martinez A J, Visvesvara G S. Free-living, amphizoic and opportunistic amebas. Brain Pathol. 1997; 7 583-598
• 137 Singhal T, Bajpai A, Kalra V et al.. Successful treatment of Acanthamoeba meningitis with combination oral antimicrobials. Pediatr Infect Dis J. 2001; 20 623-627

Joseph R ZuntM.D. M.P.H.

Department of Neurology, Harborview Medical Center

Box 359775, 325 Ninth Avenue South

Seattle, WA 98104